A Rare Case of Inflammatory Myofibroblastic Tumor Mimicking Fibrous Adhesions Resulting in Bowel Obstruction
- PMID: 39544284
- PMCID: PMC11561171
- DOI: 10.1155/2024/7782678
A Rare Case of Inflammatory Myofibroblastic Tumor Mimicking Fibrous Adhesions Resulting in Bowel Obstruction
Abstract
Inflammatory myofibroblastic tumor (IMT) is a rare mesenchymal tumors of unknown etiology composed of myofibroblastic cells admixed with inflammatory cells. Presented is a 72-year-old male hospitalized for severe abdominal pain and hematochezia with onset of associated symptoms of fever and sweats a few hours prior to abdominal pain. A computed tomography (CT) demonstrated left colonic thickening interpreted as partial obstruction, gross adhesions, and ischemia. At surgery, marked bowel ischemia from the distal transverse to proximal sigmoid colon was seen with extensive gross adhesions. Histopathology revealed a mesenteric mass chiefly composed of stellate-to-spindled myofibroblastic cells and fibrous adhesions, intermixed with lymphocytes, histiocytes, and plasma cells. The tumor was positive for desmin, smooth muscle actin, and keratin; tumor staging, grade, and postsurgical follow-up were not completed as the patient expired postoperatively. Illustrated is a rare pathologic mimic of ischemic colitis with fibrous adhesions, IMT. Thus, it should not be assumed that fibrous adhesions are always the etiology of obstruction when "adhesions" between sections of bowel are noted radiologically or surgically.
Keywords: bowel obstruction; inflammatory myofibroblastic tumor; ischemic colitis; mesenteric mass.
Copyright © 2024 Stephanie Washburn et al.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures




References
-
- Coffin C. M., Watterson J., Priest J. R., Dehner L. P. Extrapulmonary Inflammatory Myofibroblastic Tumor (inflammatory Pseudotumor). A Clinicopathologic and Immunohistochemical Study of 84 Cases. The American Journal of Surgical Pathology . 1995;19(8):859–872. doi: 10.1097/00000478-199508000-00001. - DOI - PubMed
-
- Lindeman N. I., Cagle P. T., Aisner D. L., et al. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors. Archives of Pathology & Laboratory Medicine . 2018;142(3):321–346. - PubMed
Publication types
LinkOut - more resources
Full Text Sources